ZBTB38, a novel regulator of autophagy initiation targeted by RB1CC1/FIP200 in spinal cord injury

Jie Chen, Li Yan, Haosen Wang, Zengmeng Zhang, Daolun Yu, Chaofeng Xing, Jie Li, Honglin Li, Jun Li, Yafei Cai

Research output: Contribution to journalArticle

Abstract

Apoptosis is an important contributing factor in spinal cord injury (SCI). ZBTB38 is involved in the transcriptional regulation of multiple signaling pathways, is differentially expressed at different SCI stages, and may provide a therapeutic strategy for the treatment of patients with SCI. In this study, we found that autophagy is blocked in ZBTB38 knockdown SH-SY5Y cells and that the expression levels of LC3B II/I decreased and P62 increased. We used transcriptome high-throughput sequencing to identify the target in ZBTB38 knockdown cells. From the transcriptome profile, RB1CC1 (i.e., FIP200), a key component of the initiation machinery of autophagy (FIP200-ATG13-ULK1-ATG101), was found to decrease 4.2-fold following ZBTB38 knockdown. When RB1CC1-overexpressed plasmids were transfected into ZBTB38 knockdown cells, they rescued the phenotype of ZBTB38 knockdown cells. Cell proliferation and viability were significantly enhanced by RB1CC1 overexpression, and LC3B and P62 expression returned to their original levels. We also injected ZBTB38-overexpressed lentivirus into the injured center of the spinal cord and detected significant upregulation of RB1CC1 in the spinal cord. ZBTB38 overexpression can promote autophagy and partly rescue the secondary damage of SCI. Therefore, our findings provide a new strategy for the treatment of SCI.

Original languageEnglish (US)
Pages (from-to)8-16
Number of pages9
JournalGene
Volume678
DOIs
StatePublished - Dec 15 2018

Fingerprint

Autophagy
Spinal Cord Injuries
Transcriptome
Spinal Cord
Lentivirus
Cell Survival
Plasmids
Up-Regulation
Therapeutics
Cell Proliferation
Apoptosis
Phenotype

Keywords

  • Autophagy
  • RB1CC1
  • RNA sequencing
  • Spinal Cord Injury
  • ZBTB38

ASJC Scopus subject areas

  • Genetics

Cite this

ZBTB38, a novel regulator of autophagy initiation targeted by RB1CC1/FIP200 in spinal cord injury. / Chen, Jie; Yan, Li; Wang, Haosen; Zhang, Zengmeng; Yu, Daolun; Xing, Chaofeng; Li, Jie; Li, Honglin; Li, Jun; Cai, Yafei.

In: Gene, Vol. 678, 15.12.2018, p. 8-16.

Research output: Contribution to journalArticle

Chen, J, Yan, L, Wang, H, Zhang, Z, Yu, D, Xing, C, Li, J, Li, H, Li, J & Cai, Y 2018, 'ZBTB38, a novel regulator of autophagy initiation targeted by RB1CC1/FIP200 in spinal cord injury', Gene, vol. 678, pp. 8-16. https://doi.org/10.1016/j.gene.2018.07.073
Chen, Jie ; Yan, Li ; Wang, Haosen ; Zhang, Zengmeng ; Yu, Daolun ; Xing, Chaofeng ; Li, Jie ; Li, Honglin ; Li, Jun ; Cai, Yafei. / ZBTB38, a novel regulator of autophagy initiation targeted by RB1CC1/FIP200 in spinal cord injury. In: Gene. 2018 ; Vol. 678. pp. 8-16.
@article{d0ff7fa7bac345f58939b1fb0b9006f7,
title = "ZBTB38, a novel regulator of autophagy initiation targeted by RB1CC1/FIP200 in spinal cord injury",
abstract = "Apoptosis is an important contributing factor in spinal cord injury (SCI). ZBTB38 is involved in the transcriptional regulation of multiple signaling pathways, is differentially expressed at different SCI stages, and may provide a therapeutic strategy for the treatment of patients with SCI. In this study, we found that autophagy is blocked in ZBTB38 knockdown SH-SY5Y cells and that the expression levels of LC3B II/I decreased and P62 increased. We used transcriptome high-throughput sequencing to identify the target in ZBTB38 knockdown cells. From the transcriptome profile, RB1CC1 (i.e., FIP200), a key component of the initiation machinery of autophagy (FIP200-ATG13-ULK1-ATG101), was found to decrease 4.2-fold following ZBTB38 knockdown. When RB1CC1-overexpressed plasmids were transfected into ZBTB38 knockdown cells, they rescued the phenotype of ZBTB38 knockdown cells. Cell proliferation and viability were significantly enhanced by RB1CC1 overexpression, and LC3B and P62 expression returned to their original levels. We also injected ZBTB38-overexpressed lentivirus into the injured center of the spinal cord and detected significant upregulation of RB1CC1 in the spinal cord. ZBTB38 overexpression can promote autophagy and partly rescue the secondary damage of SCI. Therefore, our findings provide a new strategy for the treatment of SCI.",
keywords = "Autophagy, RB1CC1, RNA sequencing, Spinal Cord Injury, ZBTB38",
author = "Jie Chen and Li Yan and Haosen Wang and Zengmeng Zhang and Daolun Yu and Chaofeng Xing and Jie Li and Honglin Li and Jun Li and Yafei Cai",
year = "2018",
month = "12",
day = "15",
doi = "10.1016/j.gene.2018.07.073",
language = "English (US)",
volume = "678",
pages = "8--16",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",

}

TY - JOUR

T1 - ZBTB38, a novel regulator of autophagy initiation targeted by RB1CC1/FIP200 in spinal cord injury

AU - Chen, Jie

AU - Yan, Li

AU - Wang, Haosen

AU - Zhang, Zengmeng

AU - Yu, Daolun

AU - Xing, Chaofeng

AU - Li, Jie

AU - Li, Honglin

AU - Li, Jun

AU - Cai, Yafei

PY - 2018/12/15

Y1 - 2018/12/15

N2 - Apoptosis is an important contributing factor in spinal cord injury (SCI). ZBTB38 is involved in the transcriptional regulation of multiple signaling pathways, is differentially expressed at different SCI stages, and may provide a therapeutic strategy for the treatment of patients with SCI. In this study, we found that autophagy is blocked in ZBTB38 knockdown SH-SY5Y cells and that the expression levels of LC3B II/I decreased and P62 increased. We used transcriptome high-throughput sequencing to identify the target in ZBTB38 knockdown cells. From the transcriptome profile, RB1CC1 (i.e., FIP200), a key component of the initiation machinery of autophagy (FIP200-ATG13-ULK1-ATG101), was found to decrease 4.2-fold following ZBTB38 knockdown. When RB1CC1-overexpressed plasmids were transfected into ZBTB38 knockdown cells, they rescued the phenotype of ZBTB38 knockdown cells. Cell proliferation and viability were significantly enhanced by RB1CC1 overexpression, and LC3B and P62 expression returned to their original levels. We also injected ZBTB38-overexpressed lentivirus into the injured center of the spinal cord and detected significant upregulation of RB1CC1 in the spinal cord. ZBTB38 overexpression can promote autophagy and partly rescue the secondary damage of SCI. Therefore, our findings provide a new strategy for the treatment of SCI.

AB - Apoptosis is an important contributing factor in spinal cord injury (SCI). ZBTB38 is involved in the transcriptional regulation of multiple signaling pathways, is differentially expressed at different SCI stages, and may provide a therapeutic strategy for the treatment of patients with SCI. In this study, we found that autophagy is blocked in ZBTB38 knockdown SH-SY5Y cells and that the expression levels of LC3B II/I decreased and P62 increased. We used transcriptome high-throughput sequencing to identify the target in ZBTB38 knockdown cells. From the transcriptome profile, RB1CC1 (i.e., FIP200), a key component of the initiation machinery of autophagy (FIP200-ATG13-ULK1-ATG101), was found to decrease 4.2-fold following ZBTB38 knockdown. When RB1CC1-overexpressed plasmids were transfected into ZBTB38 knockdown cells, they rescued the phenotype of ZBTB38 knockdown cells. Cell proliferation and viability were significantly enhanced by RB1CC1 overexpression, and LC3B and P62 expression returned to their original levels. We also injected ZBTB38-overexpressed lentivirus into the injured center of the spinal cord and detected significant upregulation of RB1CC1 in the spinal cord. ZBTB38 overexpression can promote autophagy and partly rescue the secondary damage of SCI. Therefore, our findings provide a new strategy for the treatment of SCI.

KW - Autophagy

KW - RB1CC1

KW - RNA sequencing

KW - Spinal Cord Injury

KW - ZBTB38

UR - http://www.scopus.com/inward/record.url?scp=85050973439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050973439&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2018.07.073

DO - 10.1016/j.gene.2018.07.073

M3 - Article

C2 - 30075197

AN - SCOPUS:85050973439

VL - 678

SP - 8

EP - 16

JO - Gene

JF - Gene

SN - 0378-1119

ER -